| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥17317.2B | ¥17761.7B | -2.5% |
| Operating Income | ¥4192.9B | ¥5135.2B | -18.3% |
| Ordinary Income | ¥4238.0B | ¥5213.9B | -18.7% |
| Net Income | ¥3601.6B | ¥4011.7B | -10.2% |
| ROE | 18.0% | 21.6% | - |
FY2026 Q3 results showed a revenue decline pattern with operating margin compression: Revenue reached ¥1,731.72B (YoY -2.5%), Operating Income ¥419.29B (YoY -18.3%), Ordinary Income ¥423.80B (YoY -18.7%), and Net Income ¥360.16B (YoY -10.2%). The company operates in a single business segment of semiconductor manufacturing equipment. The operating margin contracted to 24.2% from the prior year's 28.9%, a deterioration of approximately 470 basis points, while revenue declined modestly by 2.5%. The disproportionate decline in operating income relative to revenue indicates margin pressures from product mix shifts, cost structure changes, or pricing dynamics. Despite the profit decline, the company maintains strong profitability metrics with net margin at 20.8% and ROE at 18.0%, though these represent declines from prior year levels.
Revenue declined by 2.5% year-over-year to ¥1,731.72B from ¥1,776.17B, reflecting modest headwinds in semiconductor equipment demand. The company operates solely in the semiconductor manufacturing equipment segment, with revenue dynamics tied to global semiconductor capital investment cycles. Cost of revenue increased as a percentage of sales, with gross profit of ¥774.69B translating to a gross margin of 44.7%, down from an implied higher level in the prior year given the operating margin contraction. Selling, general and administrative expenses totaled ¥355.40B, representing 20.5% of revenue.
Operating income fell 18.3% to ¥419.29B from ¥513.52B, with the operating margin compressing from approximately 28.9% to 24.2%. This 470 basis point margin decline exceeded the revenue decline rate, suggesting multiple pressures including possible product mix deterioration toward lower-margin products, increased manufacturing costs, or competitive pricing pressures. Non-operating items contributed modestly, with ordinary income at ¥423.80B showing a net non-operating contribution of approximately ¥4.51B. Foreign exchange losses of ¥3.52B were recorded as non-operating expenses.
Net income declined 10.2% to ¥360.16B, a more moderate decline than operating income due to non-recurring factors. Investment securities sales gains of ¥38.88B were recorded as extraordinary income, partially offsetting the operating income decline. The effective tax burden resulted in income taxes of ¥106.49B. The pattern observed is revenue down/profit down with operating leverage working negatively, as fixed cost absorption deteriorated with the revenue decline and margin compression amplified the profit impact.
[Profitability] ROE of 18.0% significantly exceeds the manufacturing industry median of 5.0%, placing the company in the top quartile of industry peers, though this represents a decline from prior year levels as net income fell 10.2% while equity grew. Net profit margin of 20.8% substantially outperforms the industry median of 6.3% by 14.5 percentage points, confirming superior profitability positioning. Operating margin of 24.2% is well above the industry median of 8.3%, demonstrating strong operational efficiency despite the 470 basis point year-over-year contraction. ROA of 13.7% (calculated as net income ¥360.16B divided by total assets ¥26,350.2B) substantially exceeds the industry median of 3.3%. [Cash Quality] Cash and deposits of ¥398.48B provide coverage of 0.76x against short-term liabilities of ¥523.02B, indicating adequate but not excessive liquidity. Working capital efficiency deteriorated significantly with operating working capital turnover at 323 days versus industry median of 108 days, representing a material concern. Receivables turnover at 85 days compares unfavorably to the industry median of 83 days, while inventory turnover deteriorated sharply to 119 days versus the industry median of 109 days. [Investment Efficiency] Asset turnover of 0.66 (calculated as revenue ¥1,731.72B divided by total assets ¥26,350.2B) exceeds the industry median of 0.58, indicating efficient asset utilization. ROIC positioning remains strong relative to peers given the high operating margins. [Financial Health] Equity ratio of 76.1% (equity ¥2,005.25B divided by total assets ¥26,350.2B) substantially exceeds the industry median of 63.8%, indicating conservative capitalization. Current ratio of 312.8% (current assets ¥1,635.82B divided by current liabilities ¥523.02B) far exceeds the industry median of 284%, demonstrating strong liquidity. Financial leverage of 1.31x is below the industry median of 1.53x, reflecting the strong equity base and minimal debt usage.
Cash and deposits increased ¥60.25B year-over-year to ¥398.48B, with operating profit generation contributing to cash accumulation despite the year-over-year decline in absolute profits. Working capital movements significantly impacted cash generation, with accounts receivable increasing to ¥401.55B and inventory rising sharply to ¥310.99B, representing substantial cash consumption in working capital build. The deterioration in working capital efficiency is evidenced by DSO of 85 days and DIO of 119 days, combining for a cash conversion cycle that lengthened materially. Property, plant and equipment increased ¥127.96B or 29.9% year-over-year to ¥573.96B, indicating significant capital investment activity and capacity expansion efforts. Investment securities holdings of ¥482.32B provide additional financial flexibility. On the liability side, accounts payable increased to ¥294.63B with payables turnover at 140 days, reflecting extended supplier payment terms that partially offset the working capital consumption from receivables and inventory. Cash coverage of short-term liabilities stands at 0.76x, indicating adequate though tightened liquidity as working capital efficiency declined. The balance sheet changes suggest aggressive capacity expansion through fixed asset investment while working capital management deteriorated substantially during the period.
Ordinary income of ¥423.80B versus operating income of ¥419.29B shows a modest non-operating net contribution of approximately ¥4.51B, representing less than 1% of operating income and indicating core earnings are primarily driven by operations. Non-operating income composition includes financial income components offset by foreign exchange losses of ¥3.52B recorded during the period. The company recorded extraordinary income of ¥38.88B from investment securities sales, representing a non-recurring gain that boosted net income by approximately 10.8%. Excluding this non-recurring gain, normalized net income would have been approximately ¥321.3B, suggesting the operating profit decline more accurately reflects underlying earnings power. Non-operating and extraordinary items represent approximately 10% of pre-tax income of ¥466.31B, with the extraordinary gain providing material one-time support. While operating cash flow data is not disclosed in quarterly statements, the substantial working capital deterioration evidenced by increased DSO (85 days), DIO (119 days), and CCC (323 days versus industry median of 108 days) indicates that earnings are not efficiently converting to cash. The significant divergence between operating profit decline of 18.3% and net income decline of 10.2% stems from the non-recurring investment securities gain, which masks the underlying operational earnings quality deterioration. Overall earnings quality shows moderate concern due to working capital efficiency deterioration and reliance on non-recurring gains to support net income.
Full-year guidance projects revenue of ¥2,410.0B (YoY -0.9%), operating income of ¥593.0B (YoY -15.0%), and ordinary income of ¥601.0B (YoY -15.1%), with net income forecast at ¥550.0B and EPS of ¥1,200.05. Q3 cumulative progress versus full-year guidance shows revenue achievement of 71.9%, operating income achievement of 70.7%, and ordinary income achievement of 70.5%. These progress rates are below the standard 75% expected at Q3, indicating a shortfall of approximately 3-4 percentage points. The below-target progress suggests either conservative full-year guidance or execution challenges in the nine-month period. The implied Q4 requirements are revenue of ¥678.3B (39.2% higher than Q3 run rate if annualized cumulative divided by three), operating income of ¥173.7B, and ordinary income of ¥177.2B, representing substantial sequential improvement needed to achieve full-year targets. The guidance implies Q4 margins would need to recover materially from Q3 levels to achieve full-year profitability targets. Given the 70-72% progress rate at Q3 versus the 75% benchmark, there appears to be modest execution risk to achieving full-year guidance without stronger Q4 performance.
The company paid an interim dividend of ¥265 per share and forecasts a year-end dividend of ¥327 per share, with full-year dividend guidance of ¥337 per share. Based on full-year EPS guidance of ¥1,200.05, the implied payout ratio is 28.1%, calculated as ¥337 divided by ¥1,200.05. However, based on Q3 cumulative actual EPS of ¥785.90, the annualized payout ratio using the full-year dividend of ¥337 would be approximately 42.9% if current earnings trends continue. The company's dividend policy appears progressive with the year-end dividend of ¥327 representing a 23.4% increase over the interim ¥265, potentially reflecting confidence in Q4 performance recovery. Using actual nine-month net income of ¥360.16B and estimated share count of approximately 458 million shares (derived from EPS calculation), total nine-month dividends of ¥265 per share represent total dividend payments of approximately ¥121.4B, yielding a nine-month payout ratio of 33.7%. This moderate payout ratio provides sustainability cushion and allows for continued investment in capacity expansion evidenced by the 29.9% increase in fixed assets. No share buyback activity was disclosed in the available data. The dividend policy appears sustainable given the strong equity base of ¥2,005.25B, robust cash generation despite working capital headwinds, and moderate payout ratio, though the sustainability would be challenged if earnings decline trends continue beyond current guidance.
Semiconductor investment cycle downturn risk represents the primary business risk, with the 2.5% revenue decline and 15% forecasted full-year operating income decline indicating cyclical headwinds. The single-segment concentration in semiconductor manufacturing equipment creates earnings volatility tied to global semiconductor capex spending, with limited diversification to buffer demand fluctuations. Customer concentration and geographic exposure risks are implicit in the business model, though specific customer or regional concentrations are not quantified in available data.
Working capital management deterioration poses significant financial risk, with the cash conversion cycle extending to 323 days versus the industry median of 108 days, representing a 215-day disadvantage. This dramatic working capital inefficiency ties up approximately ¥700B in receivables and inventory, creating cash flow pressure and potential liquidity stress if the trend continues. The sharp DIO increase to 119 days and DSO of 85 days indicate either demand softening leading to inventory accumulation or supply chain timing mismatches, both of which carry carrying cost penalties and potential obsolescence risk in a technology-driven business.
Capital allocation sustainability risk emerges from the combination of aggressive fixed asset investment (up 29.9% or ¥128B year-over-year) concurrent with profit decline and working capital consumption. The ¥128B fixed asset increase implies substantial capacity expansion during a demand downturn, creating ROIC pressure and potential underutilization risk. While the current dividend payout ratio of 28-43% (depending on calculation basis) appears sustainable, the simultaneous demands of dividends, capex, and working capital financing could stress cash generation if operating performance does not recover per guidance, particularly given the 18.3% operating income decline outpacing the 2.5% revenue decline.
[Industry Position] (Reference - Proprietary Analysis) The company demonstrates exceptional profitability positioning within the manufacturing sector, with multiple metrics placing it in the top performance tier. Profitability metrics substantially exceed industry benchmarks: ROE of 18.0% versus industry median of 5.0% (ranking in top decile), net profit margin of 20.8% versus industry median of 6.3% (outperformance of 14.5 percentage points), and operating margin of 24.2% versus industry median of 8.3% (outperformance of 15.9 percentage points). These margins reflect the high value-added nature of semiconductor manufacturing equipment and the company's competitive positioning. Financial health indicators show conservative capitalization: equity ratio of 76.1% exceeds industry median of 63.8% by 12.3 percentage points, and current ratio of 312.8% far exceeds industry median of 284%, both indicating substantial financial strength. Asset efficiency metrics are mixed: asset turnover of 0.66 exceeds industry median of 0.58, demonstrating superior asset productivity, while working capital efficiency significantly underperforms with operating working capital turnover at 323 days versus industry median of 108 days, representing the company's most material competitive disadvantage. Receivables turnover at 85 days is modestly above the industry median of 83 days, while inventory turnover at 119 days exceeds the industry median of 109 days by 10 days, both contributing to working capital inefficiency. The combination of exceptional profitability, conservative balance sheet, and deteriorating working capital efficiency suggests a high-quality business facing near-term operational execution challenges in inventory and receivables management. Industry: Manufacturing sector (98 companies for most metrics, n=23-97 for specific ratios), Comparison: 2025-Q3 period, Source: Proprietary analysis.
First, the company exhibits industry-leading profitability metrics with ROE of 18.0% (versus industry median 5.0%), net margin of 20.8% (versus industry median 6.3%), and operating margin of 24.2% (versus industry median 8.3%), positioning it in the top profitability tier of manufacturing companies despite current margin compression. The 470 basis point operating margin contraction from approximately 28.9% to 24.2% alongside only a 2.5% revenue decline indicates significant operating leverage sensitivity, where small demand fluctuations create disproportionate profit impacts due to fixed cost structures inherent in semiconductor equipment manufacturing.
Second, working capital management has deteriorated markedly to become a critical earnings quality concern, with the cash conversion cycle extending to 323 days versus the industry median of 108 days, creating a 215-day competitive disadvantage. The combination of DSO at 85 days, DIO at 119 days, and DPO at 140 days indicates substantial cash trapped in the operating cycle, with approximately ¥712B tied up in receivables and inventory. This working capital inefficiency suggests either demand softness leading to inventory accumulation, extended customer payment terms in competitive markets, or supply chain timing challenges, all of which reduce cash generation quality and create potential obsolescence risk in technology equipment markets.
Third, the company is simultaneously pursuing aggressive capacity expansion with fixed assets increasing ¥128B (29.9%) while operating profits declined 18.3%, creating a cyclical timing mismatch between investment and returns. The substantial capex deployment during a profit downturn indicates either strategic positioning for anticipated future demand recovery or multi-year capacity commitments made during prior growth phases. This capital allocation pattern creates near-term ROIC pressure and heightens the importance of demand recovery to generate adequate returns on the expanded asset base, with the Q4 guidance implying material sequential improvement needed to achieve full-year targets and validate the investment cycle timing.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.